American Century Companies Inc. Boosts Stock Position in Plexus Corp. $PLXS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

American Century Companies Inc. raised its position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 24.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 678,222 shares of the technology company's stock after buying an additional 134,205 shares during the quarter. American Century Companies Inc. owned about 2.50% of Plexus worth $86,901,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. GAMMA Investing LLC lifted its position in Plexus by 49.6% during the first quarter. GAMMA Investing LLC now owns 1,333 shares of the technology company's stock valued at $171,000 after buying an additional 442 shares during the period. SG Americas Securities LLC purchased a new position in Plexus during the first quarter valued at $917,000. Ritholtz Wealth Management purchased a new position in Plexus during the first quarter valued at $285,000. Deutsche Bank AG lifted its position in Plexus by 22.8% during the first quarter. Deutsche Bank AG now owns 47,997 shares of the technology company's stock valued at $6,150,000 after buying an additional 8,921 shares during the period. Finally, Meeder Asset Management Inc. purchased a new position in Plexus during the first quarter valued at $121,000. Hedge funds and other institutional investors own 94.45% of the company's stock.

Plexus Stock Performance

PLXS traded up $6.58 during mid-day trading on Friday, reaching $137.13. 85,830 shares of the company traded hands, compared to its average volume of 179,216. The stock has a market capitalization of $3.70 billion, a P/E ratio of 23.43 and a beta of 0.80. Plexus Corp. has a 52-week low of $103.43 and a 52-week high of $172.89. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The company's fifty day moving average price is $132.30 and its 200-day moving average price is $130.17.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the company posted $1.45 earnings per share. Plexus's revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, sell-side analysts expect that Plexus Corp. will post 5.9 EPS for the current year.

Insider Buying and Selling at Plexus

In other Plexus news, insider Michael J. Running sold 646 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $130.05, for a total value of $84,012.30. Following the transaction, the insider directly owned 630 shares in the company, valued at approximately $81,931.50. This trade represents a 50.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Oliver K. Mihm sold 2,102 shares of Plexus stock in a transaction on Friday, August 15th. The stock was sold at an average price of $130.43, for a total transaction of $274,163.86. Following the transaction, the chief operating officer owned 21,155 shares in the company, valued at $2,759,246.65. This represents a 9.04% decrease in their position. The disclosure for this sale can be found here. Insiders sold 12,484 shares of company stock valued at $1,626,335 in the last quarter. Insiders own 1.76% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on PLXS. Wall Street Zen lowered Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Stifel Nicolaus set a $140.00 price target on Plexus in a research report on Thursday, July 24th. Benchmark reissued a "buy" rating and set a $160.00 price objective on shares of Plexus in a research report on Wednesday, June 4th. Needham & Company LLC reduced their price objective on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research note on Thursday, July 24th. Finally, Sidoti upgraded shares of Plexus from a "neutral" rating to a "buy" rating and upped their target price for the stock from $135.00 to $150.00 in a research note on Friday, July 25th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $152.00.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.